Through his research, Phil Baran, PhD, explores Organic synthesis, one of the great branches of Chemistry that has had a profound impact on the betterment and advancement of civilization. In its most modern manifestations, it renders the dream of alchemy (turning something worthless into something valuable) a reality. It places the practitioner into the role of artist, engineer, and astronaut. Baran’s research finds new ways to circumvent the bottlenecks of sustainable, scalable synthesis that allow organic molecules to be more rapidly transformed into viable therapies. The chemical products developed in his lab have shown major utility in a multitude of disease areas and his methods are widely used in pharmaceutical, agrochemical, and materials science sectors. Baran received a BS from New York University and a PhD from Scripps Research. He was a postdoctoral fellow at Harvard University before returning to Scripps Research as a faculty member. The mission of his laboratory is to simplify the practice of synthesis and, in doing so, educate students and postdoctoral scholars at the intersection of fundamental organic chemistry and translational science.
Baran has educated hundreds of scientists over the years, co-founded numerous companies (Sirenas, Vividion, Elsie, and several others in stealth) based on his lab’s research and is the recipient of a notable list of awards and honors that recognize the impact of his research. These include the Danisco Foundation Science Excellence Award, the Manchot Research Professorship Award, the Emanuel Merck Lectureship, the ACS Elias J. Corey Award, the Blavatnik National Laureate in Chemistry Award and a MacArthur Fellowship. Baran is also an elected member of the National Academy of Sciences, the American Academy of Arts and Sciences and a Fellow of the Royal Society of Chemistry.